Expression of receptors for advanced glycosylated end-products in renal disease

Nephrology Dialysis Transplantation

Volumn 10, Issue 9, 1995, Pages 1662-1667

  Abel, M ^a,b   Ritthaler, U ^a,b   Zhang, Y ^a,b   Deng, Y ^a,b   Schmidt, A M ^a,b   Greten, J ^a,b   Sernau, T ^a,b   Wahl, P ^a,b   Andrassy, K ^a,b   Ritz, E ^a,b   Waldherr, R ^a,b   Stern, D M ^a,b   Nawroth, P P ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

AGE; Diabetes; Endothelium; Inflammatory and or immune complex diseases; RAGE; Renal diseases

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GLYCATION; HUMAN; HUMAN EXPERIMENT; IMMUNE COMPLEX DISEASE; IMMUNOCYTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY PARENCHYMA; MALE; NEPHRECTOMY; PRIORITY JOURNAL; TECHNIQUE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; DIABETIC NEPHROPATHIES; ENDOTHELIUM, VASCULAR; EPITHELIUM; FEMALE; GLOMERULAR MESANGIUM; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMAN; IMMUNE COMPLEX DISEASES; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGE; MUSCLE, SMOOTH, VASCULAR; NEPHRITIS; RECEPTORS, IMMUNOLOGIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029116910     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a091403     Document Type: Article

References (31)

1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318(20): 1315-1321.
2. Monnier VM, Vishvanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986; 314: 403-408.
3. Schnider SL, Kohn RR. Glycosylation of human collagen in aging and diabetes mellitus. J din Invest 1980; 66: 1179-1181.
4. Makita Z, Radoff S, Rayfield EJ et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325(12): 836-842.
5. Vlassara H, Fuh FI, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA 1992; 89(24): 12043-12047.
6. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 1991; 266(18): 11654-11660.
7. Sell DR, Monnier VM. Structure elucidation of a senescent cross-link from human extracellular matrix. J Biol Chem 1989; 264: 21957-21602.
8. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. Immunohistochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Bio! Chem 1992; 267(15): 10211-10214.
9. Eble AS, Thorpe SR, Baynes JW. Nonenzymatic glycosylation and glucose-dependent cross-linking of proteins. J Biol Chem 1983; 258: 9406-9412.
10. Bucala R, Lee AT, Rourke L, Cerami A. Transposition of an alu-containing element induced by DNA-advanced glycosylation endproducts. Proc Natl Acad Sci USA 1993; 90(7): 2666-2670.
11. Yang Z, Makita Z, Horii Y et al. Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins. J Exp Med 1991; 174(3): 515-524.
12. Schmidt AM, Hori O, Brett J, Yan SD, Wautier J-L, Stem D. Cellular receptors for advanced glycation end products; implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994; 14: 1521-1528.
13. Esposito C, Gerlach H, Brett J, Stem D, Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 1989; 170(4): 1387-1407.
14. Vlassara H, Moldawer L, Chan B. Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. J Clin Invest 1989; 84(6): 1813-1820.
15. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stem D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 1993; 91(5): 2155-2168.
16. Kirstein M, Aston C, Flintz R, Vlassara H. Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest 1992 90(2): 439-446.
17. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988; 240(4858): 1546-1548.
18. Kirstein M, Brett J, Radoff S, Ogawa S, Stem D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87(22): 9010-9014.
19. Tezuka M, Koyama N, Morisaki N et al. Angiogenic effects of advanced glycation end products of the Maillard reaction on cultured human umbilical cord vein endothelial cells. Biochem Biophys Res Commun 1993; 193(2): 674-680.
20. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 1991; 174(4): 931-939.
21. Schmidt AM, Hasu M, Popov D et al. The receptor for advanced glycation endproducts (AGEs) has a central role in vessel wall interactions and gene activation in response to AGEs in the intravascular space. Proc Natl Acad Sci USA 1994; 91: 8807-8811.
22. Neeper M, Schmidt AM, Brett J et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267(21): 14998-15004.
23. Schmidt AM, Vianna M, Gerlach M et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 1992; 267(21): 14987-14997.
24. Schmidt AM, Mora R, Cao R et al. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J Biol Chem 1994; 269(13): 9882-9888.
25. Brett J, Schmidt AM, Yan SD et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993; 143(6): 1699-1712.
26. Bullock G, Petrusz P. Techniques in Immunohistochemistry, Vol. I; Academic Press, London; 1992.
27. Stemberger LA. In: Immunocytochemistry, Prentice Hall, Englewood Cliffs, 1983.
28. Ritz E, Deppisch R, Nawroth P. Toxicity of uremia—does it come of AGE? Nephrol Dial Transplant 1994; 9: 1-2.
29. Yan SD, Schmidt AM, Anderson GM et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994; 269(13): 9889-9897.
30. Wautier JL, Wautier MP, Schmidt AM et al. Advanced glycation endproducts (AGEs) on the surface of diabetic red cells bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994; 91: 7787-7791.
31. Waldherr R, Noronha IL, Niemir Z, Kruger C, Stein H, Stumm G. Expression of cytokines and growth factors in human glomerulonephritides. Pediatr Nephrol 1993, 7: 471-478.